A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
NCT02764892
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
V81444
Sponsor
Vernalis (R&D) Ltd